NEUMORA THERAPEUTICS, INC.
Assets & Liabilities
| Fiscal Year | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| FY2022 | $29.4M | $426.2M | $240.9M |
| FY2023 | $27.1M | $496.2M | $374.0M |
| FY2024 | $29.9M | $317.0M | $142.1M |
| FY2025 | $87.2M | $191.0M | $182.5M |
Assets & Liabilities
| Fiscal Year | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| FY2022 | $29.4M | $426.2M | $240.9M |
| FY2023 | $27.1M | $496.2M | $374.0M |
| FY2024 | $29.9M | $317.0M | $142.1M |
| FY2025 | $87.2M | $191.0M | $182.5M |